| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2004 | CN1524519A Lysine hydrochloride powder and injection preparation |
| 09/01/2004 | CN1524518A Use of 2-amino-2(2-(4-octyl phenyl)ethyl)-1,3-propylene glycol in the preparation of medicaments of preventing and curing immune liver injury |
| 09/01/2004 | CN1524517A Oral medicament composition containing non-steroid antiphlogistic drugs and its preparation method |
| 09/01/2004 | CN1524463A Toxin-reducing dehabit preparation of cigarette with health-care function |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164759C Method for preparing corydamine by biotransformation and use thereof in preparing analgesic |
| 09/01/2004 | CN1164675C Polymeric composition for solubilizing poorly water soluble drugs and process for preparation thereof |
| 09/01/2004 | CN1164631C Hydrogen bond receptor type spherical polymeric adsorbent and method for extracting puerarin |
| 09/01/2004 | CN1164614C Memory clearing protein and its application |
| 09/01/2004 | CN1164610C Novel anti-tumor compound Intercedenside B from picolour zhuopianshen |
| 09/01/2004 | CN1164608C Astragalus saponin A with the function of resisting myocardial fibrillation |
| 09/01/2004 | CN1164604C Acetamido lactose PEG glycoside and dimer with activity of resisting tumor metastasis |
| 09/01/2004 | CN1164603C 1,6-fructostrontium biphosphate compounds and their preparing process and medical application |
| 09/01/2004 | CN1164591C Hydrated forms of zilpatherol hydrochloride |
| 09/01/2004 | CN1164590C Imiadazodiazepine derivative |
| 09/01/2004 | CN1164579C Thiazole and oxazole derivatives and their pharmaceutical use |
| 09/01/2004 | CN1164575C Tetrahydroisoquinoline derivative with antifungal activity and its preparation method |
| 09/01/2004 | CN1164573C Novel alpha-amino acid compound, its preparation process and medicinal composition containing same |
| 09/01/2004 | CN1164526C Complex super fine powder of copper-zinc compound ,its preparing technique and usage |
| 09/01/2004 | CN1164325C Antiphlogistic capsule capable of keeping the adverse energy downwards |
| 09/01/2004 | CN1164323C Plaster for treating ischemic necrosis of femoral head |
| 09/01/2004 | CN1164320C Medicament for treating bronchial disease |
| 09/01/2004 | CN1164319C Medicament for treating epistaxis |
| 09/01/2004 | CN1164314C Achillea total flavone capsule |
| 09/01/2004 | CN1164308C Osteological Chinese medicine preparation |
| 09/01/2004 | CN1164305C Medicinal powder for curing laryngopharyngitis and ulcerations of the oral cavity |
| 09/01/2004 | CN1164302C Medicated liquor for curing burn and skin injury and its preparation method |
| 09/01/2004 | CN1164297C Use of kudzu root ,kudzu root flavone and puerarin for prevention and cure of osteoporosis |
| 09/01/2004 | CN1164288C Medicine composition for treating burns and scalds |
| 09/01/2004 | CN1164273C Natural oral liquor for treatment of women's climacteric syndrome |
| 09/01/2004 | CN1164272C Comoposition containing ligustrazine, penetrating skin paste agent of igustrazine and its preparation method |
| 09/01/2004 | CN1164271C Stable xylometazoline and oxymetazoline solution |
| 09/01/2004 | CN1164270C Application of safrole oxide in the growth and death of vascular endothelial cell |
| 09/01/2004 | CN1164269C Silybin injection containing cyclo dextrin or its derivatives |
| 09/01/2004 | CN1164268C Process for preparing simvastation drip pill |
| 09/01/2004 | CN1164267C Medical use of Chlorogenic acid and formulation thereof |
| 09/01/2004 | CN1164266C Special inhibitor for ruminant urease |
| 09/01/2004 | CN1164265C Release controlled tuoteluoding tartrate and its preparing process |
| 09/01/2004 | CN1164264C Notoginseng general saponin dispersed tablet and its preparation method |
| 09/01/2004 | CN1164263C Ambroxol-containing suctorial type tablet |
| 09/01/2004 | CN1164261C Liposome preparation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 08/31/2004 | USRE38576 Stabilized aspirin compositions and method of preparation for oral and topical use |
| 08/31/2004 | US6784315 Stilbene derivative crystal and method for producing the same |
| 08/31/2004 | US6784298 2-((3-cyclohexyl-2-(2,5-dioxo-4-(thiophen-2-yl)methylimida-zol idin-1-yl)propanoyl)amino) thiazole-4-carboxylic acid methyl ester, e.g.; antidiabetic agents; hypoglycemic agents; a glucose sensor in beta-cells and hepatocytes |
| 08/31/2004 | US6784292 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784254 Preventing reabsorption of bile acids from the intestine, decreasing lipoprotein cholesterol in the bloodstream, by oral administrating a sequester agent, crosslinked polyallylamine; better taste |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784208 Method for preventing and treating visceral pain and gastrointestinal disorders |
| 08/31/2004 | US6784207 Phytanic acid derivative compositions |
| 08/31/2004 | US6784206 Antidiabetic agents; dietetics; administering corosolic acidin soft capsules |
| 08/31/2004 | US6784205 Compounds that modulate the activity of PTP-1B and TC-PTP |
| 08/31/2004 | US6784204 Antibiotic cytosporacin |
| 08/31/2004 | US6784202 Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation |
| 08/31/2004 | US6784201 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784194 Therapeutic use of a thienylcyclohexylamine derivative |
| 08/31/2004 | US6784193 Mutilin derivatives and their use as antibacterials |
| 08/31/2004 | US6784192 Na+ channel inhibitory action is useful for therapy and prevention for example, arrhythmia, various neuralgias and analgesic |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784186 Opiods which have less activity within the central nervous system, thus having fewer undesirable side-effects |
| 08/31/2004 | US6784184 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase |
| 08/31/2004 | US6784183 Diphenylurea compounds |
| 08/31/2004 | US6784182 Serine protease inhibitors |
| 08/31/2004 | US6784181 Ligands for the delta receptor |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784178 Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity |
| 08/31/2004 | US6784177 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
| 08/31/2004 | US6784175 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
| 08/31/2004 | US6784172 Acylation of 1,4-benzodiazepines, followed by nitrosation, reduction, imination with a cyclopentanone, cyclization, reduction and deacylation |
| 08/31/2004 | US6784171 Reaction of methyl 2-amino-4-(4-fluorophenyl)-6-isopropyl-pyrimidine-5-carboxylate with methanesulfonyl chloride in the presence of strong base, reaction of the intermediate with a methylating agent in presence of strong base |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6784166 For the treatment of diseases mediated by the hepatitis c virus |
| 08/31/2004 | US6784165 Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines |
| 08/31/2004 | US6784163 Inhibition of cationic amino acid transporter protein and uses thereof |
| 08/31/2004 | US6784161 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/31/2004 | US6784160 Biologically active pregnene compounds |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783780 Nutritional supplement for the prevention and/or treatment of disorders of the digestive tract, which comprises probiotics comprising a lactic acid bacterial strain and a yeast strain of a saccharomyces species and non-digestable oligosaccharides |
| 08/31/2004 | US6783779 Food products coated with 1, 6-GPS and 1, 1-GPM |
| 08/31/2004 | US6783774 Administering topically to the bleeding site powdered d,l-threo-hex-2-enono-1,4-lactone and excipients |
| 08/31/2004 | US6783773 Composition comprising amoxicillin and potassium clavulanate |
| 08/31/2004 | US6783769 Layer of a tolterodine containing a matrix composition disposed on film, matrix is solid solution of copolymer of ethyl acrylate and methyl methacrylate and about 5% trimethylammonium ethyl methacrylate chloride and plasticizer |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | US6783757 Composition and method for increasing exorphin catabolism to treat autism |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |
| 08/31/2004 | US6782891 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/31/2004 | US6782887 Medicament respiratory delivery device and cartridge |
| 08/31/2004 | CA2293397C C-4''-substituted macrolide derivatives |
| 08/31/2004 | CA2192446C Antiviral dendrimers |
| 08/31/2004 | CA2142358C .pi.-bond aromatic vitamin chelates |